Skip to main content
. 2012 Jun 18;18(9):722–728. doi: 10.1111/j.1755-5949.2012.00349.x

Figure 6.

Figure 6

Downregulation of miR‐21 inhibits glioblastoma xenograft growth. (A) When subcutaneous tumors were established, As‐miR‐21 was injected in a multisite injection manner. Tumor volumes were measured every 3 days during treatment. (B) The expression levels of STAT3 and human telomerase reverse transcriptase were tested by immunohistochemistry analyses of xenograft tumors after As‐miR‐21 treatment. *P < 0.05 as compared with the control group.